Company: FGMCU
Filing Date: 2025-01-21
Form Type: S-1/A
Source: 0001104659-25-004764
Chunk: 115

Company: FG Merger II Corp.
Filing Date: 2025-01-21
Form: S-1/A
Chunk 115
---
 The price of the shares we issue may therefore be less, and potentially significantly less, than the
market price for our shares at such time. Any such issuances of equity securities could dilute the interests of our existing stockholders.
These financing transactions may be significantly dilutive to the post-combination company, and represent the type of financing risk
that is not associated with traditional initial public offerings. In addition, any issuance of common stock in connection with the additional
financing would result in the issuance of additional shares our initial stockholders as a result of the anti-dilution protections of
the founder shares, unless the initial stockholders waive their anti-dilution rights. If the initial stockholders do not waive their
anti-dilution rights the issuance of additional shares could make it more difficult to complete the proposed financing or make the terms
of such financing less favorable to us. If we are unable to complete our initial business combination, our public stockholders may only
receive their pro rataportion of the funds in the trust account that are available for distribution to public stockholders, and
our rights will expire worthless. In addition, even if we do not need additional financing to complete our initial business combination,
we may require such financing to fund the operations or growth of the target business. The failure to secure additional financing could
have a material adverse effect on the continued development or growth of the target business. None of our officers, directors or stockholders
is required to provide any financing to us in connection with or after our initial business combination.

Our initial stockholders control a substantial interest in us and thus may exert a substantial influence on actions requiring a stockholder vote, potentially in a manner that you do not support.

Upon the closing of this offering, our initial stockholders will own
20% of our issued and outstanding common stock (assuming they do not purchase any units in this offering and excluding the shares of
common stock underlying the public rights, the Underwriter Units, the EarlyBird Units, the private units, the $15 Exercise Price Warrants
and the units issuable upon conversion of any working capital loans). Accordingly, they may exert a substantial influence on actions
requiring a stockholder vote, potentially in a manner that you do not support, including amendments to our amended and restated articles
of incorporation. If our initial stockholders purchase any units in this offering or if our initial stockholders purchase any additional
common stock in the aftermarket or in privately negotiated transactions, this would increase their control.